World Malaria Day 2009
- Filed under: Health News
- Date: Apr 22,2009
If you're new here, you may want to subscribe to my RSS feed. Thanks for visiting!
“Working in Partnership: Innovating Medicines to Eradicate Malaria”
Panel Discussion Hosted by Medicines for Malaria Venture,
United Nations Office for Partnerships and Novartis
WHAT:
Medicines for Malaria Venture, United Nations Office for Partnerships and Novartis will host a luncheon panel, “Working in Partnership: Innovating Medicines to Eradicate Malaria,” leading up to the Second Annual World Malaria Day. The luncheon is part of a global discussion on the critical role of private-public partnerships in fostering research and development of life-saving anti-malarial medicines. The panel will also discuss how – through partnership and science – the global community can realize the Millennium Development Goal of halting and reversing the incidence of malaria by 2015 and the ultimate goal of malaria eradication.
WHO:
H.E. Dr. Augustine P. Mahiga, Ambassador Extraordinary and Plenipotentiary, Permanent Representative of Tanzania to the United Nations
H.E. Mr. Peter Mauer, Ambassador Extraordinary and Plenipotentiary, Permanent Representative of Switzerland to the United Nations
Mr. Amir Dossal, Executive Director, United Nations Office for Partnerships
Mr. Antony Kalm, Vice President Corporate Development, Medicines for Malaria Venture
Mr. Hans Rietveld, Director of Global Access and Marketing, Novartis Malaria Initiatives
Mr. Alan Court, Senior Advisor, United Nation’s Secretary General’s Envoy for Malaria
WHEN: Wednesday, April 22, 2009 1:00 p.m.
WHERE:
United Nations Delegates Dining Room, Room 6 United Nations Building 4th Floor New York
WHY:
Malaria kills up to one million people annually. The majority of malaria’s victims are children under five and pregnant women. In Africa, a child dies every 30 seconds from malaria. Each year up to 250 million clinical cases of malaria are reported worldwide; medicines are critically needed to cure these potentially fatal infections.
Medicines for Malaria Venture, a not-for-profit public-private partnership, was established as a foundation in Switzerland in 1999. It is dedicated to reducing the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs. Our vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease. For more information, visit www.mmv.org.
Leave a comment